Table 31 (Abstract P86). See text for description
From: Proceedings of the 24th Paediatric Rheumatology European Society Congress: Part one
PATIENTS` CHARACTERITICS (N = 76) | ||
|---|---|---|
Gender (Male), | 23 (30,3) | |
Age (years), median (IR) n (%) | 10,83 (8,52-13,54) | |
25OH-Vitamin D (ng/mL), mean (+/-SD) | 34,04Â ng/mL (8,90Â ng/mL) | |
DISEASE CHARACTERISTICS (N = 76) | ||
JIA subtype, n (%) | Systemic | 9 (11,8) |
Oligoarticular | 47 (61,9) | |
Polyarticular | 20 (26,3) | |
Inflammatory activity duration (days), median (IR) | 385,0(246,75-761,25) | |
RECEIVED TREATMENTS (N = 76)* | ||
Systemic GC, n (%) | 61 (80,2) | |
Synthetic DMARDs treatment, n (%) | 39 (51,3) | |
Biological DMARDs treatment subtype, n(%) | Anti-TNFα | 15 (19,7) |
Anti-IL1 | 4 (5,2) | |
Anti-IL6 | 2 (2,6) | |